About US

About Journal

Welcome to Research journal of Cancer, a peer-reviewed journal that provides the latest research on Research journal of cancer treatment, a peer-reviewed journal that provides the latest research on radiation oncology and cancer treatment. Our mission is to disseminate high-quality, cutting-edge research to healthcare professionals, researchers, and scholars around the world.

 

Our journal is committed to promoting open access to scientific knowledge, making our research available to all who seek to learn and advance in the field of radiation oncology and cancer treatment. We strive to create a global community of researchers and practitioners who share our passion for advancing cancer treatment and improving patient outcomes.



Research journal of Cancer covers different aspects of Oncology, Tumor, Malignant, Benign, Metastasis, Chemotherapy, Radiation therapy, Immunotherapy, Biopsy, Carcinogen, Stage, Remission, Survivorship, Genetics, Risk factors, Advance directive, Ablative therapy, Cancer And Stem Cell Biology; Cancer Epidemiology; Cancer Biomarkers; Mechanisms of Drug Sensitivity and Resistance; Oncology Clinical Trials; Carcinogenesis & Mutagenesis; Tumor Virology; Basic And Clinical Immunology; Cancer Toxicology; Cancer Pharmacodynamics; Radiation Oncology; Cancer Risk Assessment; Cancer Treatment; Cancer Genomics & Proteomics; Cancer Pharmaceutics; Medical Oncology; Myelodysplastic Syndromes; Myeloproliferative Disorders; Clinical Ethics; Latest Cancer Treatment Breakthroughs; Latest Research On Cancer Treatments; Immunotheraphy; CD24; Cancer Patients with COVID-19;  Melanoma

 

 

 





 

 

Topics

Oncology
Tumor
Malignant
Benign
Metastasis
Chemotherapy
Radiation therapy
Immunotherapy
Biopsy
Carcinogen
Remission
Survivorship
Genetics
Risk factors
Advance directive
Ablative therapy
Cancer And Stem Cell Biology
Cancer Epidemiology
Cancer Biomarkers
Mechanisms of Drug Sensitivity and Resistance
Oncology Clinical Trials
Carcinogenesis & Mutagenesis
Tumor Virology
Basic And Clinical Immunology
Cancer Toxicology
Cancer Pharmacodynamics
Radiation Oncology
Cancer Risk Assessment
Cancer Treatment
Cancer Genomics & Proteomics
Cancer Pharmaceutics
Medical Oncology
Myelodysplastic Syndromes
Myeloproliferative Disorders
Clinical Ethics
Latest Cancer Treatment Breakthroughs
Latest Research On Cancer Treatments
Immunotheraphy
CD24
Cancer Patients with COVID-19
Melanoma

Journal Features:

International peer review research journal that publishes articles on multidisciplinary fields.

Prompt acknowledgement after receiving the article.

Rigorous double blind peer review evaluation.

No charges for article submission.

Rapid publication after the acceptance of article through eminent reviewers and editor.

Publication of manuscripts with the fulfilment of excellence, novelty and originality.

Nominal publication charges.

Greater visibility of your valuable published work.

Best platform for sharing the knowledge globally.

Issue of Publication Certificate to author.

Issue of Editorial Board Member Certificate to EBM member.

Issue of reviewer Certificate to reviewer.

About UR Forum Publishers

UR Forum Publishers is a scientifically independent open access publisher whose mission is to publish new research by bridging the gap between research and practise, with the goal of resulting in societal benefits. Our peer-reviewed publications cover a wide range of medical research, healthcare, and other topics. We are dedicated to publishing high-quality research articles that have an impact and are long-lasting, resulting in a better future for future generations.

Researchers and academics can use UR Forum Publishers to disseminate scientific knowledge to a wider audience, gain media attention, and demonstrate professional progress through publication. The Open Access concept allows for unrestricted access to published content that is not time-limited, as well as the ability to reprint and distribute original content. We publish the work of eminent scientists, young researchers, and academic and industrial professionals. Because our journals adhere to the criteria and principles of the Directory of Open Access Journals, viewing the full text of articles does not require a subscription (DOAJ).

We are a committed group of educators and technocrats with extensive industry experience. Our torchbearers are eminent scientists, educators, industrialists, and officials from around the world who serve on the editorial board. Our team is working hard to connect available talent and resources in order to form partnerships that will promote research collaboration. Our common goal is to support research and discoveries that benefit the community and advance technology.

By embracing best practises and technology to deliver unique science books, journals, and series, UR Forum has remained at the forefront of academic publishing. Our entry into the exciting world of online publications and eBooks was a natural and seamless transition. This step is an extension of our vision to publish the best works by outstanding scientists from around the world and make them available to as many people as possible.

In almost every country, UR Forum has representatives, agents, and distributors. They provide review copies upon request, advertise academic journals in specialised catalogues, and exhibit at international trade shows such as the London, US, and international academic book events.